The request follows a review by the FDA that found no evidence linking GLP-1 receptor agonists to an increased risk of suicidal thoughts or behavior.
Markets
About Us
Contact Us
- 333, Pali Pathar, Khar West, Mumbai, Maharashtra 400052
- Pjazza Mifsud Bonnici, Marsascala, Malta
- info@markettrade.live
- +919769768500
